Burning Rock Biotech Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Burning Rock Biotech Limited (BNR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of CNY 15.78 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-04-28
CNY
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2025-12-31 | 15.78M CNY 20-F · filed 2026-04-28 |
| 2024-12-31 | 27.66M CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 229.00K CNY 20-F · filed 2026-04-28 |
| 2022-12-31 | 1.69M CNY 20-F · filed 2025-04-29 |
| 2021-12-31 | 8.36M CNY 20-F · filed 2024-04-29 |
| 2020-12-31 | 1.86M CNY 20-F · filed 2023-04-20 |
| 2019-12-31 | 121.04M CNY 20-F · filed 2022-04-29 |
USD
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2025-12-31 | $2.26M 20-F · filed 2026-04-28 |
| 2024-12-31 | $3.79M 20-F · filed 2025-04-29 |
| 2023-12-31 | $32.00K 20-F · filed 2024-04-29 |
| 2022-12-31 | $244.00K 20-F · filed 2023-04-20 |
| 2021-12-31 | $1.31M 20-F · filed 2022-04-29 |